Description of Cefepime

Cefepime is a fourth-generation cephalosporin antibacterial developed in 1994. Cefepime has an continued spectrum of action adjoin Gram-positive and Gram-negative bacteria, with greater action adjoin both Gram-negative and Gram-positive bacilli than third-generation agents. Cefepime is usually aloof to amusement astringent nosocomial pneumonia, infections acquired by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empiric analysis of delirious neutropenia.

Cefepime is a fourth-generation cephalosporin antibacterial developed in 1994. Cefepime has an continued spectrum of action adjoin Gram-positive and Gram-negative bacteria, with greater action adjoin both Gram-negative and Gram-positive bacilli than third-generation agents. Cefepime has acceptable action adjoin important bacilli including Pseudomonas aeruginosa, Staphylococcus aureus, and assorted biologic aggressive Streptococcus pneumoniae. A accurate backbone is its action adjoin Enterobacteriaceae. Whereas added cephalosporins are base by abounding plasmid- and chromosome-mediated beta-lactamases, cefepime is abiding and is a foreground band abettor if infection with Enterobacteriaceae is accepted or suspected.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s